title: General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations.
authors.forename: Masood A
authors.initials: MA
authors.lastname: Khan
mesh_terms: D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000601:surgery*
chemical_list: D017430:Prostate-Specific Antigen